Insulin Companies Start Dropping Prices by 70% or More. Why, though?
Novo Nordisk, a leading healthcare company, has joined competitor Eli Lilly in chopping the price of insulin for medicare patients by 75%, with Lilly starting at a 70% reduction and a monthly out-of-pocket cap for insulin. This is a…